HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review.

Abd El-Baky, Nawal; Amara, Amro A; Redwan, Elrashdy M

Abd El-Baky, Nawal; Amara, Amro A; Redwan, Elrashdy M.

Afiliación

Abd El-Baky N; Protein Research Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Alexandria P.O. Box 21934, Egypt.
Amara AA; Protein Research Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Alexandria P.O. Box 21934, Egypt.
Redwan EM; Biological Sciences Department, Faculty of Science, King Abdulaziz University, Jeddah P.O. Box 80203, Saudi Arabia.

Vaccines (Basel) ; 11(3)2023 Feb 25.

Article en En | MEDLINE | ID: mdl-36992131

Palabras clave

HLA-I; HLA-II; MHCs; SARS-CoV-2; T-cell-mediated immunity; immunopeptidomics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google